CARTER TODD ALFRED (Chief Scientific Officer) sold 8.4% of their position (5.50K shares) of VOYAGER THERAPEUTICS, INC. on the open market
Open‑market sale worth $59.4K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 7/10/2023ACC: 0001104659-23-079686
Officer· Chief Scientific Officer
Since Feb 2026
-5.50K
Net shares
Net seller
$59.4K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
5.50K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−5.50K
Price / share
$10.80
Trade value
$59.40K
% of position
8.4%
7/6/2023
65.36K→59.86K
Total
Net shares
−5.50K
Net value
-$59.40K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/6/2023 | S · Sale | −5.50K | $10.80 | $59.40K | 8.4% | 65.36K | 59.86K |
| Total | −5.50K | -$59.40K | ||||||
Derivative Transactions0
No derivative transactions reported